quinoxalines has been researched along with Neovascularization, Optic Disc in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avraham-Lubin, BC; Cohen, Y; Dadon-Bar-El, S; Dratviman-Storobinsky, O; Goldenberg-Cohen, N; Hasanreisoglu, M; Weinberger, D | 1 |
| Bai, Y; Gil, DW; Kusari, J; Le, YZ; Padillo, E; Song, Z; Wang, J; Zhou, SX; Zhu, M | 1 |
2 other study(ies) available for quinoxalines and Neovascularization, Optic Disc
| Article | Year |
|---|---|
Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy.
Topics: Animals; Brimonidine Tartrate; Disease Models, Animal; Eye Proteins; Fluorescent Antibody Technique, Indirect; Gene Expression; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Heme Oxygenase-1; Hypoxia-Inducible Factor 1, alpha Subunit; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neuroprotective Agents; Nitric Oxide Synthase Type III; Optic Neuropathy, Ischemic; Oxidative Stress; Quinoxalines; Receptor Protein-Tyrosine Kinases; Receptor, TIE-2; Retinal Ganglion Cells; Retinal Neovascularization; Serpins; Superoxide Dismutase; Superoxide Dismutase-1; Vascular Endothelial Growth Factor A | 2009 |
Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Fluorescein Angiography; Humans; Immunoblotting; Infant, Newborn; Intravitreal Injections; Laser Coagulation; Male; Mice; Mice, Inbred C57BL; Oxygen; Quinoxalines; Rabbits; Rats; Rats, Inbred BN; Retinal Neovascularization; Retinopathy of Prematurity; Time Factors | 2011 |